📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa. (2023)

First Author: Asare K

Attributed to: Addressing challenges in scaling up TB and HIV treatment integration in public health settings in South Africa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ofid/ofad583

PubMed Identifier: 38045558

Publication URI: http://europepmc.org/abstract/MED/38045558

Type: Journal Article/Review

Volume: 10

Parent Publication: Open forum infectious diseases

Issue: 12

ISSN: 2328-8957